3 unknown, 1 recruiting, 1 withdrawn. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 1, Withdrawn 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Jun Zhu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product Peripheral blood mononuclear cell apheresis - Healthy Subject | Not applicable | Unknown | Jun Zhu | 172 | 2020-04-01 | 2021-06-09 |
| China Lymphoma Patient Registry Study Lymphoma | Recruiting | Jun Zhu | 5000 | 2017-05-17 | 2017-10-18 | |
| A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation Tropisetron, Dexamethasone, Aprepitant - Vomiting | Phase 4 | Unknown | Jun Zhu | 130 | 2015-10-01 | 2016-12-30 |
| A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib crizotinib - Systemic Anaplastic Large-Cell Lymphoma | Phase 4 | Withdrawn | Jun Zhu | 2015-07-01 | 2016-12-30 | |
| MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma R-MT followed by auto-HSCT - Primary Central Nervous System Lymphoma | Phase 2 | Unknown | Jun Zhu | 39 | 2014-05-01 | 2015-04-13 |
Lymphoma (2) · Hematologic Neoplasms (1) · Lymphoma, Large-Cell, Anaplastic (1) · Vomiting (1)
Aprepitant (1) · Crizotinib (1) · Dexamethasone (1) · R-CHOP protocol (1) · Tropisetron (1) · dexamethasone 21-phosphate (1)
China (4)